GlaxoSmithKline PLC ADR (GSK) — Financial Flexibility Index
GlaxoSmithKline PLC ADR (GSK) has a Financial Flexibility Index of 0.06x as of June 2026. Free cash flow of $2.86 Billion (operating CF $2.54 Billion minus capex $328.95 Million) represents 0% of total liabilities ($44.29 Billion). Check how aggressively does GlaxoSmithKline PLC ADR reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
GlaxoSmithKline PLC ADR Financial Flexibility Index (1990–2025)
Historical Financial Flexibility Index trend for GlaxoSmithKline PLC ADR across 36 annual periods. For the full cash flow conversion analysis, see GSK operating cash flow.
Annual Financial Flexibility Index for GlaxoSmithKline PLC ADR (1990–2025)
Year-by-year free cash flow to debt coverage for GlaxoSmithKline PLC ADR. Explore GlaxoSmithKline PLC ADR cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.19x | $8.46 Billion | $7.14 Billion | $45.02 Billion | ▼ -8.6% |
| 2024 | 0.21x | $9.54 Billion | $6.55 Billion | $46.38 Billion | ▲ +27.2% |
| 2023 | 0.16x | $9.52 Billion | $7.89 Billion | $58.91 Billion | ▼ -16.2% |
| 2022 | 0.19x | $9.66 Billion | $7.40 Billion | $50.05 Billion | ▲ +38.8% |
| 2021 | 0.14x | $10.88 Billion | $7.95 Billion | $78.23 Billion | ▲ +6.2% |
| 2020 | 0.13x | $10.68 Billion | $8.44 Billion | $81.50 Billion | ▲ +4.6% |
| 2019 | 0.13x | $10.18 Billion | $8.02 Billion | $81.25 Billion | ▼ -33.3% |
| 2018 | 0.19x | $10.22 Billion | $8.42 Billion | $54.39 Billion | ▲ +8.9% |
| 2017 | 0.17x | $9.12 Billion | $6.92 Billion | $52.89 Billion | ▲ +5.5% |
| 2016 | 0.16x | $8.85 Billion | $6.50 Billion | $54.12 Billion | ▲ +63.0% |
| 2015 | 0.10x | $4.47 Billion | $2.57 Billion | $44.57 Billion | ▼ -48.3% |
| 2014 | 0.19x | $6.93 Billion | $5.18 Billion | $35.72 Billion | ▼ -25.5% |
| 2013 | 0.26x | $8.92 Billion | $7.22 Billion | $34.27 Billion | ▲ +53.4% |
| 2012 | 0.17x | $5.89 Billion | $4.38 Billion | $34.73 Billion | ▼ -27.8% |
| 2011 | 0.23x | $7.58 Billion | $6.25 Billion | $32.25 Billion | ▼ -10.0% |
| 2010 | 0.26x | $8.43 Billion | $6.80 Billion | $32.31 Billion | ▼ -13.7% |
| 2009 | 0.30x | $9.71 Billion | $7.84 Billion | $32.12 Billion | ▲ +0.2% |
| 2008 | 0.30x | $9.38 Billion | $7.31 Billion | $31.07 Billion | ▼ -23.4% |
| 2007 | 0.39x | $8.31 Billion | $6.17 Billion | $21.09 Billion | ▲ +10.5% |
| 2006 | 0.36x | $5.67 Billion | $4.08 Billion | $15.90 Billion | ▼ -5.2% |
| 2005 | 0.38x | $7.38 Billion | $6.20 Billion | $19.63 Billion | ▲ +23.0% |
| 2004 | 0.31x | $5.20 Billion | $4.94 Billion | $17.01 Billion | ▼ -20.0% |
| 2003 | 0.38x | $5.91 Billion | $4.85 Billion | $15.49 Billion | ▲ +33.0% |
| 2002 | 0.29x | $4.29 Billion | $3.06 Billion | $14.94 Billion | ▼ -32.0% |
| 2001 | 0.42x | $5.73 Billion | $4.61 Billion | $13.57 Billion | ▲ +80.5% |
| 2000 | 0.23x | $2.96 Billion | $1.85 Billion | $12.63 Billion | ▲ +52.8% |
| 1999 | 0.15x | $1.11 Billion | $510.00 Million | $7.23 Billion | ▲ +13.7% |
| 1998 | 0.13x | $885.00 Million | $410.00 Million | $6.58 Billion | ▼ -14.5% |
| 1997 | 0.16x | $1.03 Billion | $615.00 Million | $6.55 Billion | ▼ -11.3% |
| 1996 | 0.18x | $1.25 Billion | $849.00 Million | $7.05 Billion | ▼ -23.8% |
| 1995 | 0.23x | $1.94 Billion | $1.25 Billion | $8.32 Billion | ▼ -40.3% |
| 1994 | 0.39x | $2.93 Billion | $2.45 Billion | $7.53 Billion | ▼ -34.4% |
| 1993 | 0.59x | $1.63 Billion | $1.05 Billion | $2.74 Billion | ▲ +8.5% |
| 1992 | 0.55x | $1.53 Billion | $927.00 Million | $2.80 Billion | ▼ -10.5% |
| 1991 | 0.61x | $1.25 Billion | $657.00 Million | $2.04 Billion | ▲ +23.5% |
| 1990 | 0.50x | $1.22 Billion | $615.00 Million | $2.46 Billion | — |